About your organization

RTsafe was established in 2014 to commercialize the internationally patented PseudoPatient® idea. The basic component of which is to build an exact replica of patient’s head to be radiotherapy treated and tested, before his/her actual treatment, aiming to verify and secure the safety and quality of life of the patient treated. PseudoPatient® has already been awarded (R&D100 award, 1st prize in MIT Enterprise Forum), and has top-scored among the 250 initial participants and the 5 finalists of the Startup3 2020-21 programme.

In July 2019, our proposal gained the seal-of-excellence under the SME Inst. ph. II. Furthermore, over 70 peer-revewed papers have already been published proving high appreciation by the scientific community of PseudoPatient® solution.

Additionally, the PseudoPatient® idea has attracted radiotherapy equipment manufacturers as a means of testing, commissioning and quality assurance (machine QA) tool (using treatment-simulation plans). 

The production line is currently based in Athens utilizing 3D printing, CNC, and dosimetric gel-polymerized technologies.

RTsafe Holding Ltd. is established in Ireland which owns 100% of RTsafe P.C. (Greece), and RTsafe Inc. (USA). Company shareholders own shares only of the Holding entity, which owns 100% of the IP rights of the International Patent of the PseudoPatient® offering. Company has achieved to gain – apart from various awards - FDA 510(k) clearance for the US market and is ISO13485 and ISO9001 certified. 

News

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.